A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma

Don Eslin, Peter E. Zage, Genevieve Bergendahl, Elizabeth Lewis, William Roberts, Jacqueline Kraveka, Deanna Mitchell, Michael S. Isakoff, Jawhar Rawwas, Randal K. Wada, Mark Fluchel, Valerie I. Brown, Kevin Ginn, Timothy Higgins, Abhinav BeeravallyNagulapally, Karl Dykema, Gina Hanna, William Ferguson, Giselle L. Saulnier Sholler

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences